| Monday June 23, 2025 Abstract Session 10 – CRS – Medical management 1 ROOM 11 (G10) | Level +1 09:10h – 10:25h ABSTRACTS
|
| Chair : Yi-Tsen Lin |
| 4093 – Comparison of the performance of ChatGPT and ENT physicians in the management of chronic diffuse rhinosinusitis |
| Golzan Romane |
| 4284 – Budesonide, A Novel Intrapolyp Injection Agent. |
| Gehad Ibrahim |
| 3676 – Study on the mechanism of vitamin D inhibiting pyroptosis of human nasal epithelial cells and enhancing glucocorticoid sensitivity |
| Li yue |
| 3701 – Effectiveness of ASA therapy after ASA desensitization on adult N-ERD and CRSwNP patients |
| Toppila-Salmi Sanna |
| 4016 – Management of patients with Chronic Rhinosinusitis with nasal polyps in clinical practice: French Society of Oto-Rhino-Laryngology Head and Neck Surgery (SFORL) consensus guidelines |
| Papon Jean Francois |
| 4036 – Antimicrobial activity of Simvastatin against chronic rhinosinusitis-related Staphylococcus aureus: an in vitro study |
| Goldie Simon |
| 4058 – Corticosteroid nasal irrigations are comparable to corticosteroid sprays in topical treatment of eosinophilic chronic rhinosinusitis in late postoperative period |
| Cabernite-Marchetti Erika |
| 4171 – Indication for biologic treatment in a real-world cohort of chronic rhinosinusitis patients according to international recommendations: Evidence from the European CRS Outcome Registry (CHRINOSOR) |
| Otten Josje |
